For primary prevention in diabetes, a practical panel could include HbA1c (glycemic control), an inflammatory marker (hs‐CRP or IL‐6), an endothelial marker (sVCAM‐1 or ADMA), kidney function (albuminuria and/or eGFR), and a lipoprotein measure (Lp(a)). This evidence concerns the gene CRP and diabetes mellitus.